 | • レポートコード：QYR2104Z4260 • 出版社/出版日：QYResearch / 2021年4月 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、99ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療 |
| Single User | ￥546,000 (USD3,900) | ▷ お問い合わせ |
| Multi User/Five User | ￥819,000 (USD5,850) | ▷ お問い合わせ |
| Enterprise License（同一法人内共有可） | ￥1,092,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYResearch社発行の本調査資料では、腫瘍溶解性ウイルス免疫療法のグローバル市場（2016年～2027年）について調べ、市場動向、主要企業の市場シェア、種類別市場規模（腫瘍溶解性ウイルスエンジニアリング、野生型腫瘍溶解性ウイルス）、用途別市場規模（病院、診療所、外来手術センター）、主要地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、関連企業情報などを掲載しています。 ・市場概要 ・腫瘍溶解性ウイルス免疫療法の市場動向 ・企業の競争状況、市場シェア ・腫瘍溶解性ウイルス免疫療法の種類別市場規模（腫瘍溶解性ウイルスエンジニアリング、野生型腫瘍溶解性ウイルス） ・腫瘍溶解性ウイルス免疫療法の用途別市場規模（病院、診療所、外来手術センター） ・腫瘍溶解性ウイルス免疫療法の北米市場規模2016-2027（アメリカ、カナダ） ・腫瘍溶解性ウイルス免疫療法のヨーロッパ市場規模2016-2027（ドイツ、フランス、イギリス等） ・腫瘍溶解性ウイルス免疫療法のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・腫瘍溶解性ウイルス免疫療法の中南米市場規模2016-2027（メキシコ、ブラジル） ・腫瘍溶解性ウイルス免疫療法の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Amgen、TILT Biotherapeutics、Oncorus、Sorrento Therapeutics、Shanghai Sunway Biotech） ・結論 |
Oncology Immunotherapy exploits virus’s ability to replicate selectively and kill tumor tissue while at the same time regulate the specific immune response of a patient The first oncolytic virus to demonstrate a clinical benefit in patients with melanoma is genetically modified herpes simplex virus type I i.e. Talimogene laherparepvec (T-VEC).
North America is leading in the oncolytic virus immunotherapy market globally, according to Skin Cancer Foundation Statistics, Globally 132,000 melanoma skin cancers occur each year. One in every three cancers diagnosed is a skin cancer, and one in every five Americans will develop skin cancer in their lifetime. North America has well-developed healthcare infrastructure with massive investment in research and development of oncolytic virus immunotherapy.
Market Analysis and Insights: Global Oncolytic Virus Immunotherapy Market
The global Oncolytic Virus Immunotherapy market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Oncolytic Virus Immunotherapy market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Oncolytic Virus Immunotherapy market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Oncolytic Virus Immunotherapy market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Oncolytic Virus Immunotherapy market.
Global Oncolytic Virus Immunotherapy Scope and Market Size
Oncolytic Virus Immunotherapy market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Oncolytic Virus Immunotherapy market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.
Segment by Type
Engineering Oncolytic Viruses
Wild-Type Oncolytic Viruses
Segment by Application
Hospitals
Clinics
Ambulatory Surgical Centers
By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
By Company
Merck
Amgen
TILT Biotherapeutics
Oncorus
Sorrento Therapeutics
Shanghai Sunway Biotech
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Engineering Oncolytic Viruses
1.2.3 Wild-Type Oncolytic Viruses
1.3 Market by Application
1.3.1 Global Oncolytic Virus Immunotherapy Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Ambulatory Surgical Centers
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Oncolytic Virus Immunotherapy Market Perspective (2016-2027)
2.2 Oncolytic Virus Immunotherapy Growth Trends by Regions
2.2.1 Oncolytic Virus Immunotherapy Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Oncolytic Virus Immunotherapy Historic Market Share by Regions (2016-2021)
2.2.3 Oncolytic Virus Immunotherapy Forecasted Market Size by Regions (2022-2027)
2.3 Oncolytic Virus Immunotherapy Industry Dynamic
2.3.1 Oncolytic Virus Immunotherapy Market Trends
2.3.2 Oncolytic Virus Immunotherapy Market Drivers
2.3.3 Oncolytic Virus Immunotherapy Market Challenges
2.3.4 Oncolytic Virus Immunotherapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue
3.1.1 Global Top Oncolytic Virus Immunotherapy Players by Revenue (2016-2021)
3.1.2 Global Oncolytic Virus Immunotherapy Revenue Market Share by Players (2016-2021)
3.2 Global Oncolytic Virus Immunotherapy Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Oncolytic Virus Immunotherapy Revenue
3.4 Global Oncolytic Virus Immunotherapy Market Concentration Ratio
3.4.1 Global Oncolytic Virus Immunotherapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Oncolytic Virus Immunotherapy Revenue in 2020
3.5 Oncolytic Virus Immunotherapy Key Players Head office and Area Served
3.6 Key Players Oncolytic Virus Immunotherapy Product Solution and Service
3.7 Date of Enter into Oncolytic Virus Immunotherapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Oncolytic Virus Immunotherapy Breakdown Data by Type
4.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Type (2016-2021)
4.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2022-2027)
5 Oncolytic Virus Immunotherapy Breakdown Data by Application
5.1 Global Oncolytic Virus Immunotherapy Historic Market Size by Application (2016-2021)
5.2 Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2022-2027)
6 North America
6.1 North America Oncolytic Virus Immunotherapy Market Size (2016-2027)
6.2 North America Oncolytic Virus Immunotherapy Market Size by Type
6.2.1 North America Oncolytic Virus Immunotherapy Market Size by Type (2016-2021)
6.2.2 North America Oncolytic Virus Immunotherapy Market Size by Type (2022-2027)
6.2.3 North America Oncolytic Virus Immunotherapy Market Size by Type (2016-2027)
6.3 North America Oncolytic Virus Immunotherapy Market Size by Application
6.3.1 North America Oncolytic Virus Immunotherapy Market Size by Application (2016-2021)
6.3.2 North America Oncolytic Virus Immunotherapy Market Size by Application (2022-2027)
6.3.3 North America Oncolytic Virus Immunotherapy Market Size by Application (2016-2027)
6.4 North America Oncolytic Virus Immunotherapy Market Size by Country
6.4.1 North America Oncolytic Virus Immunotherapy Market Size by Country (2016-2021)
6.4.2 North America Oncolytic Virus Immunotherapy Market Size by Country (2022-2027)
6.4.3 United States
6.4.3 Canada
7 Europe
7.1 Europe Oncolytic Virus Immunotherapy Market Size (2016-2027)
7.2 Europe Oncolytic Virus Immunotherapy Market Size by Type
7.2.1 Europe Oncolytic Virus Immunotherapy Market Size by Type (2016-2021)
7.2.2 Europe Oncolytic Virus Immunotherapy Market Size by Type (2022-2027)
7.2.3 Europe Oncolytic Virus Immunotherapy Market Size by Type (2016-2027)
7.3 Europe Oncolytic Virus Immunotherapy Market Size by Application
7.3.1 Europe Oncolytic Virus Immunotherapy Market Size by Application (2016-2021)
7.3.2 Europe Oncolytic Virus Immunotherapy Market Size by Application (2022-2027)
7.3.3 Europe Oncolytic Virus Immunotherapy Market Size by Application (2016-2027)
7.4 Europe Oncolytic Virus Immunotherapy Market Size by Country
7.4.1 Europe Oncolytic Virus Immunotherapy Market Size by Country (2016-2021)
7.4.2 Europe Oncolytic Virus Immunotherapy Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic
8 Asia-Pacific
8.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size (2016-2027)
8.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Type
8.2.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Type (2016-2027)
8.3 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Application
8.3.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Application (2016-2027)
8.4 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region
8.4.1 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Oncolytic Virus Immunotherapy Market Size (2016-2027)
9.2 Latin America Oncolytic Virus Immunotherapy Market Size by Type
9.2.1 Latin America Oncolytic Virus Immunotherapy Market Size by Type (2016-2021)
9.2.2 Latin America Oncolytic Virus Immunotherapy Market Size by Type (2022-2027)
9.2.3 Latin America Oncolytic Virus Immunotherapy Market Size by Type (2016-2027)
9.3 Latin America Oncolytic Virus Immunotherapy Market Size by Application
9.3.1 Latin America Oncolytic Virus Immunotherapy Market Size by Application (2016-2021)
9.3.2 Latin America Oncolytic Virus Immunotherapy Market Size by Application (2022-2027)
9.3.3 Latin America Oncolytic Virus Immunotherapy Market Size by Application (2016-2027)
9.4 Latin America Oncolytic Virus Immunotherapy Market Size by Country
9.4.1 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2016-2021)
9.4.2 Latin America Oncolytic Virus Immunotherapy Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Oncolytic Virus Immunotherapy Market Size (2016-2027)
10.2 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Type
10.2.1 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Type (2016-2027)
10.3 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Application
10.3.1 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Application (2016-2027)
10.4 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country
10.4.1 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Oncolytic Virus Immunotherapy Introduction
11.1.4 Merck Revenue in Oncolytic Virus Immunotherapy Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Amgen
11.2.1 Amgen Company Details
11.2.2 Amgen Business Overview
11.2.3 Amgen Oncolytic Virus Immunotherapy Introduction
11.2.4 Amgen Revenue in Oncolytic Virus Immunotherapy Business (2016-2021)
11.2.5 Amgen Recent Development
11.3 TILT Biotherapeutics
11.3.1 TILT Biotherapeutics Company Details
11.3.2 TILT Biotherapeutics Business Overview
11.3.3 TILT Biotherapeutics Oncolytic Virus Immunotherapy Introduction
11.3.4 TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2016-2021)
11.3.5 TILT Biotherapeutics Recent Development
11.4 Oncorus
11.4.1 Oncorus Company Details
11.4.2 Oncorus Business Overview
11.4.3 Oncorus Oncolytic Virus Immunotherapy Introduction
11.4.4 Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2016-2021)
11.4.5 Oncorus Recent Development
11.5 Sorrento Therapeutics
11.5.1 Sorrento Therapeutics Company Details
11.5.2 Sorrento Therapeutics Business Overview
11.5.3 Sorrento Therapeutics Oncolytic Virus Immunotherapy Introduction
11.5.4 Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2016-2021)
11.5.5 Sorrento Therapeutics Recent Development
11.6 Shanghai Sunway Biotech
11.6.1 Shanghai Sunway Biotech Company Details
11.6.2 Shanghai Sunway Biotech Business Overview
11.6.3 Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Introduction
11.6.4 Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2016-2021)
11.6.5 Shanghai Sunway Biotech Recent Development
12 Analyst’s Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Table 1. Global Oncolytic Virus Immunotherapy Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Engineering Oncolytic Viruses
Table 3. Key Players of Wild-Type Oncolytic Viruses
Table 4. Global Oncolytic Virus Immunotherapy Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 5. Global Oncolytic Virus Immunotherapy Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 6. Global Oncolytic Virus Immunotherapy Market Size by Regions (2016-2021) & (US$ Million)
Table 7. Global Oncolytic Virus Immunotherapy Market Share by Regions (2016-2021)
Table 8. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 9. Global Oncolytic Virus Immunotherapy Market Share by Regions (2022-2027)
Table 10. Oncolytic Virus Immunotherapy Market Trends
Table 11. Oncolytic Virus Immunotherapy Market Drivers
Table 12. Oncolytic Virus Immunotherapy Market Challenges
Table 13. Oncolytic Virus Immunotherapy Market Restraints
Table 14. Global Oncolytic Virus Immunotherapy Revenue by Players (2016-2021) & (US$ Million)
Table 15. Global Oncolytic Virus Immunotherapy Market Share by Players (2016-2021)
Table 16. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus Immunotherapy as of 2020)
Table 17. Ranking of Global Top Oncolytic Virus Immunotherapy Companies by Revenue (US$ Million) in 2020
Table 18. Global 5 Largest Players Market Share by Oncolytic Virus Immunotherapy Revenue (CR5 and HHI) & (2016-2021)
Table 19. Key Players Headquarters and Area Served
Table 20. Key Players Oncolytic Virus Immunotherapy Product Solution and Service
Table 21. Date of Enter into Oncolytic Virus Immunotherapy Market
Table 22. Mergers & Acquisitions, Expansion Plans
Table 23. Global Oncolytic Virus Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 24. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2016-2021)
Table 25. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 26. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 27. Global Oncolytic Virus Immunotherapy Market Size Share by Application (2016-2021) & (US$ Million)
Table 28. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2016-2021)
Table 29. Global Oncolytic Virus Immunotherapy Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 30. Global Oncolytic Virus Immunotherapy Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 31. North America Oncolytic Virus Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 32. North America Oncolytic Virus Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 33. North America Oncolytic Virus Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 34. North America Oncolytic Virus Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 35. North America Oncolytic Virus Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 36. North America Oncolytic Virus Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 37. Europe Oncolytic Virus Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 38. Europe Oncolytic Virus Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 39. Europe Oncolytic Virus Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 40. Europe Oncolytic Virus Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 41. Europe Oncolytic Virus Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 42. Europe Oncolytic Virus Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 43. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 44. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 46. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2016-2021) & (US$ Million)
Table 48. Asia-Pacific Oncolytic Virus Immunotherapy Market Size by Region (2022-2027) & (US$ Million)
Table 49. Latin America Oncolytic Virus Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 50. Latin America Oncolytic Virus Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 51. Latin America Oncolytic Virus Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 52. Latin America Oncolytic Virus Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 53. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 54. Latin America Oncolytic Virus Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 55. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Type (2016-2021) (US$ Million)
Table 56. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Type (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Application (2016-2021) (US$ Million)
Table 58. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Application (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2016-2021) & (US$ Million)
Table 60. Middle East & Africa Oncolytic Virus Immunotherapy Market Size by Country (2022-2027) & (US$ Million)
Table 61. Merck Company Details
Table 62. Merck Business Overview
Table 63. Merck Oncolytic Virus Immunotherapy Product
Table 64. Merck Revenue in Oncolytic Virus Immunotherapy Business (2016-2021) & (US$ Million)
Table 65. Merck Recent Development
Table 66. Amgen Company Details
Table 67. Amgen Business Overview
Table 68. Amgen Oncolytic Virus Immunotherapy Product
Table 69. Amgen Revenue in Oncolytic Virus Immunotherapy Business (2016-2021) & (US$ Million)
Table 70. Amgen Recent Development
Table 71. TILT Biotherapeutics Company Details
Table 72. TILT Biotherapeutics Business Overview
Table 73. TILT Biotherapeutics Oncolytic Virus Immunotherapy Product
Table 74. TILT Biotherapeutics Revenue in Oncolytic Virus Immunotherapy Business (2016-2021) & (US$ Million)
Table 75. TILT Biotherapeutics Recent Development
Table 76. Oncorus Company Details
Table 77. Oncorus Business Overview
Table 78. Oncorus Oncolytic Virus Immunotherapy Product
Table 79. Oncorus Revenue in Oncolytic Virus Immunotherapy Business (2016-2021) & (US$ Million)
Table 80. Oncorus Recent Development
Table 81. Sorrento Therapeutics Company Details
Table 82. Sorrento Therapeutics Business Overview
Table 83. Sorrento Therapeutics Oncolytic Virus Immunotherapy Product
Table 84. Sorrento Therapeutics Revenue in Oncolytic Virus Immunotherapy Business (2016-2021) & (US$ Million)
Table 85. Sorrento Therapeutics Recent Development
Table 86. Shanghai Sunway Biotech Company Details
Table 87. Shanghai Sunway Biotech Business Overview
Table 88. Shanghai Sunway Biotech Oncolytic Virus Immunotherapy Product
Table 89. Shanghai Sunway Biotech Revenue in Oncolytic Virus Immunotherapy Business (2016-2021) & (US$ Million)
Table 90. Shanghai Sunway Biotech Recent Development
Table 91. Research Programs/Design for This Report
Table 92. Key Data Information from Secondary Sources
Table 93. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Oncolytic Virus Immunotherapy Market Share by Type: 2020 VS 2027
Figure 2. Engineering Oncolytic Viruses Features
Figure 3. Wild-Type Oncolytic Viruses Features
Figure 4. Global Oncolytic Virus Immunotherapy Market Share by Application: 2020 VS 2027
Figure 5. Hospitals Case Studies
Figure 6. Clinics Case Studies
Figure 7. Ambulatory Surgical Centers Case Studies
Figure 8. Oncolytic Virus Immunotherapy Report Years Considered
Figure 9. Global Oncolytic Virus Immunotherapy Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 10. Global Oncolytic Virus Immunotherapy Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Oncolytic Virus Immunotherapy Market Share by Regions: 2020 VS 2027
Figure 12. Global Oncolytic Virus Immunotherapy Market Share by Regions (2022-2027)
Figure 13. Global Oncolytic Virus Immunotherapy Market Share by Players in 2020
Figure 14. Global Top Oncolytic Virus Immunotherapy Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Oncolytic Virus Immunotherapy as of 2020
Figure 15. The Top 10 and 5 Players Market Share by Oncolytic Virus Immunotherapy Revenue in 2020
Figure 16. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2016-2021)
Figure 17. Global Oncolytic Virus Immunotherapy Revenue Market Share by Type (2022-2027)
Figure 18. North America Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 19. North America Oncolytic Virus Immunotherapy Market Share by Type (2016-2027)
Figure 20. North America Oncolytic Virus Immunotherapy Market Share by Application (2016-2027)
Figure 21. North America Oncolytic Virus Immunotherapy Market Share by Country (2016-2027)
Figure 22. United States Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 23. Canada Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 24. Europe Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Europe Oncolytic Virus Immunotherapy Market Share by Type (2016-2027)
Figure 26. Europe Oncolytic Virus Immunotherapy Market Share by Application (2016-2027)
Figure 27. Europe Oncolytic Virus Immunotherapy Market Share by Country (2016-2027)
Figure 28. Germany Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 29. France Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 30. U.K. Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. Italy Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. Russia Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Nordic Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Asia-Pacific Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Asia-Pacific Oncolytic Virus Immunotherapy Market Share by Type (2016-2027)
Figure 36. Asia-Pacific Oncolytic Virus Immunotherapy Market Share by Application (2016-2027)
Figure 37. Asia-Pacific Oncolytic Virus Immunotherapy Market Share by Region (2016-2027)
Figure 38. China Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 39. Japan Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 40. South Korea Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Southeast Asia Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. India Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Australia Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. Latin America Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Latin America Oncolytic Virus Immunotherapy Market Share by Type (2016-2027)
Figure 46. Latin America Oncolytic Virus Immunotherapy Market Share by Application (2016-2027)
Figure 47. Latin America Oncolytic Virus Immunotherapy Market Share by Country (2016-2027)
Figure 48. Mexico Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 49. Brazil Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 50. Middle East & Africa Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Middle East & Africa Oncolytic Virus Immunotherapy Market Share by Type (2016-2027)
Figure 52. Middle East & Africa Oncolytic Virus Immunotherapy Market Share by Application (2016-2027)
Figure 53. Middle East & Africa Oncolytic Virus Immunotherapy Market Share by Country (2016-2027)
Figure 54. Turkey Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 55. Saudi Arabia Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 56. UAE Oncolytic Virus Immunotherapy Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Merck Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2016-2021)
Figure 58. Amgen Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2016-2021)
Figure 59. TILT Biotherapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2016-2021)
Figure 60. Oncorus Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2016-2021)
Figure 61. Sorrento Therapeutics Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2016-2021)
Figure 62. Shanghai Sunway Biotech Revenue Growth Rate in Oncolytic Virus Immunotherapy Business (2016-2021)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed
世界の腫瘍溶解性ウイルスがん免疫療法市場規模・現状・予測（2021年-2027年） Oncolytic virus is a special virus that can beneficially infect and kill cancer cells. These are deployed as part of cancer immunotherapy and work by selectively targeting cancer cells and performing oncolytics. Oncolytic viruses can not only kill cancer cells directly, but also stimulate patients' …- 世界のヒトパラインフルエンザウイルス診断市場規模・現状・予測（2021年-2027年） Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers…
- 世界のヒトパラインフルエンザウイルス診断市場規模・現状・予測（2021年-2027年） Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers…
- 世界の肝炎ウイルス迅速検査市場規模・現状・予測（2021年-2027年） Market Analysis and Insights: Global Hepatitis Viruses Rapid Tests Market The global Hepatitis Viruses Rapid Tests market size is projected to reach US$ XX million by 2026, from US$ XX million in 2019, at a CAGR of XX% during 2021-2026. With industry-standard accuracy in analysis and high data integ…
- 世界のB型肝炎ウイルス（HBV）市場規模・現状・予測（2021年-2027年） Over the recent years, the global Hepatitis B Treatment industry has been driven by the increasing number of patients diagnosed with Chronic Hepatitis B which results in severe complications, rising awareness about the consequences of viral infection, rigorous efforts to eliminate the viral infectio…